Oxalo Therapeutics, Inc. is a Chicago-based company dedicated to the development of groundbreaking therapies for patients suffering from severe and rare kidney diseases caused by oxalate.
With a strong commitment to innovation, Oxalo focuses on providing effective treatments for these specific conditions, aiming to improve the lives of those affected by oxalate-related kidney diseases.
Generated from the website
